Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,366 | 8,210 | 18,011 | 23,587 | 19,467 |
| Marketable Securities | 21,318 | 8,477 | 9,085 | 7,154 | 1,972 |
| Receivables | 23,559 | 1,671 | 1,402 | 3,719 | 13,706 |
| TOTAL | $61,585 | $20,459 | $30,656 | $36,358 | $36,906 |
| Non-Current Assets | |||||
| PPE Net | 8,844 | 8,720 | 8,918 | 5,835 | 5,117 |
| Investments And Advances | 0 | 36,539 | 57,963 | 33,733 | 108,206 |
| Intangibles | 61,723 | 62,298 | 62,806 | 3,125 | 3,600 |
| Other Non-Current Assets | 826 | 23,675 | 23,372 | 22,609 | 22,248 |
| TOTAL | $71,393 | $131,232 | $153,059 | $65,302 | $139,171 |
| Total Assets | $132,978 | $151,691 | $183,715 | $101,660 | $176,077 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,842 | 6,859 | 7,336 | 6,463 | 4,082 |
| Other current liabilities | N/A | N/A | 372 | N/A | N/A |
| TOTAL | $6,162 | $7,859 | $8,723 | $6,812 | $4,503 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 182 | 44 | 43 | 42 | 120 |
| Other Non-Current Liabilities | 4,637 | 4,466 | 4,886 | 2,286 | 1,849 |
| TOTAL | $11,297 | $12,073 | $13,756 | $2,602 | $2,016 |
| Total Liabilities | $17,459 | $19,932 | $22,479 | $9,414 | $6,519 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 149,794 | 149,643 | 149,643 | 149,361 | 126,964 |
| Common Shares | 386,454 | 385,615 | 384,553 | 354,270 | 386,858 |
| Retained earnings | -268,940 | -252,435 | -222,403 | -261,856 | -216,905 |
| Other shareholders' equity | -1,995 | -1,421 | -914 | -168 | -395 |
| TOTAL | $115,519 | $131,759 | $161,236 | $92,246 | $169,558 |
| Total Liabilities And Equity | $132,978 | $151,691 | $183,715 | $101,660 | $176,077 |